Britannica Sources used in this answer

How do drugs control ion channels in cell membranes?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Gleevec; imatinib — drug Docking of the anticancer drug Gleevec (imatinib) in the abl domain of the bcr-abl tyrosine kinase. Abnormalities in bcr-abl stimulate the continuous proliferation of bone marrow stem cells, causing an increase in myelogenous cells (granulocytes and macrophages) in the body and leading to chronic myelogenous leukemia (CML).

Ion channels are specialized proteins in cell membranes that regulate the flow of ions, such as sodium, potassium, and calcium, to facilitate essential physiological processes like electrical signaling and muscle contraction.1

Drugs control these channels by acting directly or indirectly to modulate their activity. Many ion channels are "gated," meaning they open or close in response to specific stimuli. Drugs can influence these gates through several mechanisms:1

Ligand-like interaction: Some drugs act as ligands, binding to the channel protein to trigger a conformational change that opens or closes the channel.1
Inhibition: Certain therapeutic agents and natural toxins function as blockers, preventing ions from passing through the channel pore.1
Indirect modulation: Drugs may influence the cellular environment or regulatory proteins that control channel gating, rather than binding to the channel itself.1

By targeting these proteins, drugs can alter the membrane's electrical state, which is critical for treating conditions such as cardiac arrhythmias, epilepsy, and pain. Research continues to focus on developing compounds with higher specificity to improve therapeutic outcomes while minimizing side effects.1